要するに・・・
回復者への接種が多い国ほどワクチンの効果（VE）が高くなるわけですよ。
でもそれはワクチンの効果じゃなくて回復者のワクチンの27倍もの免疫力のお陰なんですよ。だからロックダウンでゼロコロナ戦略を徹底した国ほどワクチンが効かない。それはワクチンの効果（VE）が回復者への接種により水増しされてた数字だからなんですね。
米国のEUA（Emergency Use Authorization）の最低基準であるVE=50％を満たす統計的結果を得るために回復者数を２０００万人と過少に見積もり（ホントは一億人以上）そして不必要な接種を行ったわけです。（爆ｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗ
3 件のコメント:
地震頻発してますねー
ワクチン義務化まで進めないと…ってことなんでしょうかｗ
脅迫が露骨Deathねｗ
サンプル数の数合わせ
サクラ動員
・・・あ、ポトマック川のサクラか（爆
酷い話だ
Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity:
reinfections versus breakthrough infections
https://www.medrxiv.org/content/10.1101/2021.08.24.21262415v1
"During the follow-up period, 257 cases of SARS-CoV-2 infection were recorded, of which 238 occurred in the vaccinated group (breakthrough infections) and 19 in the previously infected group (reinfections). After adjusting for comorbidities, we found a statistically significant 13.06-fold (95% CI, 8.08 to 21.11) increased risk for breakthrough infection as opposed to reinfection (P<0.001). Apart from age ≥60 years, there was no statistical evidence that any of the assessed comorbidities significantly affected the risk of an infection during the follow-up period (Table 2a). As for symptomatic SARS-COV-2 infections during the follow-up period, 199 cases were recorded, 191 of which were in the vaccinated group and 8 in the previously infected group. Symptoms for all analyses were recorded in the central database within 5 days of the positive RT-PCR test for 90% of the patients, and included chiefly fever, cough, breathing difficulties, diarrhea, loss of taste or smell, myalgia, weakness, headache and sore throat. After adjusting for comorbidities, we found a 27.02-fold risk (95% CI, 12.7 to 57.5) for symptomatic breakthrough infection as opposed to symptomatic reinfection (P<0.001) (Table 2b). None of the covariates were significant, except for age ≥60 years."
コメントを投稿